Malaysia’s Major Glove free of charge to export to US soon after ban lifted

KUALA LUMPUR — The U.S. has lifted a ban on imports of health-related gloves designed by Prime Glove, according to U.S. Customs and Border Safety and the Malaysian firm.

The agency, which is element of the Division of Homeland Security, said in a notice published Friday on the web page of the Federal Register that it found the gloves “are no longer currently being mined, developed, or manufactured wholly or in element with the use of convict, pressured, or indentured labor by Top Glove in Malaysia.”

Top rated Glove is the world’s major maker of latex professional medical gloves.

“CBP has now identified, dependent upon supplemental information, that this sort of merchandise is no for a longer period getting, or is likely to be, imported into the United States in violation of part 307 of the Tariff Act of 1930, as amended,” reads the notice.

The CBP in July past 12 months issued a withhold release purchase on gloves produced by Leading Glove, indicating that they were produced by overseas workers in Malaysia underneath abusive conditions including debt bondage and dangerous functioning environments.

“Considering that that time, Top Glove has supplied further info to CBP, which CBP believes establishes by satisfactory evidence that the subject disposable gloves are no for a longer period mined, developed, or created in any part with pressured labor,” it mentioned.

Best Glove reported in a statement that its healthcare gloves would resume becoming allowed in at all U.S. ports of entry starting off Friday.

“Prime Glove needs to categorical its utmost appreciation to CBP for its responsiveness in modification of the obtaining,” the firm stated. “Top rated Glove continues to be fully commited to the well being, safety and effectively-remaining of its folks.” 

The firm’s share price rallied 10% in early buying and selling Friday on the announcement, before giving up most of the gains to trade 2% higher at midday. The extended ban in the US and the development of the COVID-19 vaccine experienced sent Prime Glove’s stock price down by about 60% in the very last 12 months.

The CBP ban also dampened production in Malaysian factories and delayed Prime Glove’s prepared listing in Hong Kong, where it is hoping to raise over $1 billion.